Hexarelin
5mg
❄️Lyophilized powder (not reconstituted)
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 10 | 10% | €35.99 |
| 11 - 20 | 15% | €33.99 |
| 21+ | 20% | €31.99 |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: €39.99
Hexarelin is supplied as a catalogued research material in 5mg.
The catalogue name identifies hexarelin/examorelin but does not state whether the vial contains the free peptide, acetate, TFA or another form. Parent and acetate records are chemically distinct, so formula, mass and registry identifiers remain conditional on the matching batch identity report [1,2].
Chemical properties and registry information
| Property | Value |
|---|---|
| Name and synonyms | Examorelin, EP-23905 |
| Material category | Growth Hormone Secretagogue |
| Sequence | H-His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2 |
| Molecular formula | C47H58N12O6 |
| Average molecular mass | 887.04 g/mol |
| CAS Registry Number | 140703-51-1 |
| PubChem CID | CID 9831664 |
| Structural features | Synthetic hexapeptide containing non-natural D-amino acids (D-2-Methyltryptophan, D-Phenylalanine) and a C-terminal amidation. It is an analog of GHRP-6. |
| Appearance | White to off-white lyophilised powder |
| Solubility | Soluble in bacteriostatic or sterile water. |
| Physical form | Catalogue vial; exact salt/counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.
A potent, synthetic growth hormone secretagogue that acts as an agonist at the ghrelin/growth hormone secretagogue receptor (GHSR).
Research background and published evidence
Published research
IUPHAR classifies examorelin/hexarelin as a peptidic growth-hormone secretagogue. A defined reference can be used in GHSR ligand-binding, receptor-signalling and analytical-assay research when sequence, stereochemistry and salt form are controlled [3].
Current scientific understanding
Receptor classification and experimental endocrine observations do not establish long-term safety, efficacy, dosage, administration, or medicine authorization. They also do not verify identity, purity, amount or salt form for this catalogue batch [1–3].
Hexarelin is specifically covered by current anti-doping restrictions [4].
Technical comparison
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Catalogue hexarelin with unconfirmed free-peptide or salt form | A defined hexarelin acetate reference with specified stoichiometry |
| Structural distinction | The name establishes the parent sequence but not counter-ion or salt equivalents | Acetate identity and counter-ion contribution are explicitly defined |
| Analytical implication | Verify D-2-MeTrp/D-Phe configuration, C-terminal amide, intact mass, salt, purity and net parent content | Reference mass and registry values apply only to the matching defined salt form |
Quality and testing
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Laboratory handling and storage
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
Regulatory and legal status
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Sources and references
- [1] PubChem. Examorelin/hexarelin parent structure, CID 6918297.
- [2] PubChem. Distinct hexarelin acetate record, CID 21885907.
- [3] IUPHAR/BPS Guide to Pharmacology. Examorelin/hexarelin ligand record.
- [4] World Anti-Doping Agency. 2026 Prohibited List.
Frequently Asked Questions
Do the CAS number and PubChem CID apply to every batch form?
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
What does an analytical purity result mean?
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
How should the material be stored and handled?
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.